May 12 is ME/CFS Awareness Day. Fuel progress all month long—join the May Momentum campaign!
The ME/CFS Collaborative Research Center (previously known as the CFS Research Center) at Stanford University was established in 2014 and is part of the Stanford Genome Technology Center. Both centers are directed by Ronald W. Davis, PhD, Professor of Biochemistry and of Genetics at Stanford.
Latest Video
Throughout his career, Dr. Davis has conducted cutting edge, innovative, interdisciplinary research and technology development on cancer, immunology, genetics, infectious disease, novel drug development, and nanofabrication of diagnostic instruments.
Dr. Davis was the first to physically map the genome of any organism (1968).
Dr. Davis discovered a simple way to join together DNA from two organisms (“sticky ends”) and was the first to generate a hybrid DNA molecule that could replicate inside of cells (DNA cloning).
This project aims to characterize the mitochondrial function in whole peripheral blood mononuclear cells (PBMCs) in ME/CFS.
This project aims to develop and use a platform that can evaluate neutrophil dysfunction in ME/CFS.
This project aims to characterize viral factors associated with immune responses and inflammation in ME/CFS.
The goal of the project is to develop, characterize, and validate a microfluidic chip for the estimation of biomechanical properties of red blood cells (RBCs) isolated from ME/CFS patients vis-à-vis healthy controls.
This project aims to test whether genetic markers and other indicators of BH4 deficiency are also present in subjects with Long COVID.
This technology demonstrates a significant difference between ME / CFS patients and healthy controls.
The goal of this study was to extend the Severely ill Patient Study and conduct a comprehensive “Big Data” analysis on ME/CFS patients and their families.
Director
Ronald W. Davis, PhD, Professor of Biochemistry and Genetics, Stanford University School of Medicine; Director, Stanford Genome Technology Center; Director, Chronic Fatigue Syndrome Research Center at Stanford University; Chair, Open Medicine Foundation ME/CFS Scientific Advisory Board.
Collaborative Research Center / Stanford Genome Technology Center
Robert Phair, PhD
Wenzhong Xiao, PhD
Mohsen Nemat-Gorgani, PhD
Peidong Shen, PhD
Laurel Crosby, PhD
Michael Jensen
Fereshteh Jahaniani, PhD
Gozde Durmus, PhD
Julie Wilhelmy
Alex Kashi
Anand Ramasubramanian, PhD
Amit Saha, PhD
Layla Cervantes
Ami Mac, MD
David Kaufman, MD
Bela Chheda, MD
Chris Armstrong, PhD
Katrina Hong
Anna Okumu
Ashley Haugen
Collaborators
Juan Santiago, PhD
Eric Shaqfeh, PhD
Mark M. Davis, PhD
Michael Sikora
Mike Snyder, PhD
Craig Heller, PhD
Lars Steinmetz, PhD
Jonas Bergquist, MD, PhD
Rahim Esfandyarpour, PhD
Curt Scharfe, MD
Robert Naviaux, MD, PhD
William Robinson, MD
Lucinda Bateman, MD
Jennifer Frankovich, MD
In Memoriam – Ron Tompkins, MD, ScD
Please help us expand our research efforts across the globe. Every donation brings us closer to a fully-funded research effort and the answers we all seek.
OMF is a non-profit 501(c)(3) organization
(EIN# 26-4712664). All donations are tax-deductible to the extent allowed by law.
Open Medicine Foundation®
29302 Laro Drive, Agoura Hills, CA 91301 USA
Phone: 650-242-8669
info@omf.ngo
Copyright © 2025 Open Medicine Foundation. All Rights Reserved.
What are the advantages of giving from your Donor Advised Fund (DAF)?
How do I make a donation through my DAF?
Just click on the DAF widget below. It is simple and convenient to find your fund among the over 900 funds in our system.
Still can’t find your fund?
Donate your appreciated stock directly to OMF and you can receive an immediate income-tax deduction for the fair market value of the securities on the date of transfer (even if you originally paid much less for them).Gifting of Stock
Broker: Schwab
DTC #: 0164
Account #: 47083887
Account Registered as:
Open Medicine Foundation
29302 Laro Drive
Agoura Hills, CA 91301
Please speak to your personal tax advisor and then email or call OMF at 650-242-8669 to notify us of your donation or with any questions.
